Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_4
1
17%
Ph phase_3
3
50%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(2)

Detailed Status

Recruiting3
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 33 (50.0%)
Phase 41 (16.7%)

Trials by Status

completed233%
not_yet_recruiting117%
recruiting350%

Recent Activity

3 active trials
Showing 5 of 6
recruitingphase_3

A Study of Dotinurad Versus Allopurinol in Participants With Gout

NCT07089875
recruitingphase_3

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

NCT07089888
not_yet_recruitingphase_2

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

NCT07535034
recruitingphase_4

Effect of Dotinurad in Hyperuricemia With Hypertension

NCT06834230
completedphase_3

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

NCT05007392
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07089875Phase 3

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Recruiting
NCT07089888Phase 3

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

Recruiting
NCT07535034Phase 2

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

Not Yet Recruiting
NCT06834230Phase 4

Effect of Dotinurad in Hyperuricemia With Hypertension

Recruiting
NCT05007392Phase 3

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

Completed
NCT05278676Phase 1

A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6